Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.
Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gomez I, Benítez García B, Guijarro LG, Marin A, Bernardo D, Gisbert JP; PREDICROHN Study Group from GETECCU.
Chaparro M, et al. Among authors: hinojosa j.
Eur J Gastroenterol Hepatol. 2020 May;32(5):588-596. doi: 10.1097/MEG.0000000000001706.
Eur J Gastroenterol Hepatol. 2020.
PMID: 32251204